Inventor · disambiguated record
Martin John Evans
Also filed as: EVANS MARTIN JOHN
8 granted patents·13 pending applications·31 citations·filing 1989–2020
79Inventor score
Files withCELL THERAPY LTD11CANCER REC TECH LTD3BABRAHAM INST2CANCER RES TECH LTD1CANCER RESEARCH TECH LTD1
Top patents by PatentIndex Score
21 records- 0177US11304981B2Platelet lysate gelCELL THERAPY LTD·Filed 2018·Granted Apr 19, 2022·1 cites·1 claims
- 0267US10829739B2Progenitor cells of mesodermal lineageCELL THERAPY LTD·Filed 2019·Granted Nov 10, 2020·0 cites·5 claims
- 0365US11873513B2Progenitor cells of mesodermal lineageCELL THERAPY LTD·Filed 2020·Granted Jan 16, 2024·0 cites·9 claims
- 0464US6436701B1Derivation of pluripotential embryonic cell lines from ungulate speciesBABRAHAM INST·Filed 1989·Granted Aug 20, 2002·30 cites·2 claims
- 0558US2015047064A1INHIBITING GENE EXPRESSION WITH dsRNACANCER REC TECH LTD·Filed 2014·Application pending·0 cites
- 0658US2008221054A1Inhibiting Gene Expression with dsRNACANCER REC TECH LTD·Filed 2007·Application pending·0 cites
- 0758US2008242628A1Inhibiting Gene Expression with dsRNACANCER REC TECH LTD·Filed 2007·Application pending·0 cites
- 0855US2018355352A1INHIBITING GENE EXPRESSION WITH dsRNACANCER RESEARCH TECH LTD·Filed 2017·Application pending·0 cites
- 0954US10117898B2Platelet lysate gelCELL THERAPY LTD·Filed 2017·Granted Nov 6, 2018·0 cites·2 claims
- 1053US2017096667A1INHIBITING GENE EXPRESSION WITH dsRNACANCER RES TECH LTD·Filed 2016·Application pending·0 cites
- 1148US2014335195A1Platelet lysate gelCELL THERAPY LTD·Filed 2012·Application pending·0 cites
- 1245US10472609B2Progenitor cells of mesodermal lineageHOUZE THOMAS AVERELL·Filed 2012·Granted Nov 12, 2019·0 cites·24 claims
- 1345US2002187549A1Derivation of pluripotential embryonic cell lines from domestic animalsBABRAHAM INST·Filed 2002·Application pending·0 cites
- 1444US2003027783A1Inhibiting gene expression with dsRNAFiled 2002·Application pending·0 cites
- 1543US12029763B2Immuno-modulatory progenitor (IMP) cellCELL THERAPY LTD·Filed 2015·Granted Jul 9, 2024·0 cites·3 claims
- 1643US2019142869A1Immuno-modulatory progenitor (imp) cellCELL THERAPY LTD·Filed 2019·Application pending·0 cites
- 1740US2016123980A1Multicolor flow cytometry method for identifying a population of cells, in particular mesenchymal stem cellsCELL THERAPY LTD·Filed 2014·Application pending·0 cites
- 1837US2018085434A1CompositionCELL THERAPY LTD·Filed 2016·Application pending·0 cites
- 1931US2009276864A1Transgenic animals with reduced major urinary protein productionEVANS MARTIN JOHN·Filed 2005·Application pending·0 cites
- 2030US10316291B2Immuno-oncology mesodermal progenitor (ioMP) cellCELL THERAPY LTD·Filed 2016·Granted Jun 11, 2019·0 cites·3 claims
- 2126US2017119930A1Hybrid compositionCELL THERAPY LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin John Evans files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →